The oligonucleotide synthesis market progressed significantly in the recent past. The main reason for this is the growing number of research activities in synthetic biology, the increasing occurrence of cancer and communicable ailments, progressions in technologies of oligonucleotide synthesis, and promising government rules. This market is divided into reagents and consumables, synthesized oligonucleotides, and equipment. The growth of synthesized oligonucleotides was the highest in the global scenario.
Cancer is one of the most prevalent and potent diseases happening in the world, and the number of people suffering and dying is constantly increasing. By the year 2040, there will be a total of 27.5 million cancer cases and 16.3 million deaths due to cancer just because of the increase in the aging population. The future could be rather gloomy because of the increasing occurrence of factors increasing risk like smoking, unhealthy diet regime, physical idleness, and fewer deliveries, in developing countries.
The progress of the microarray technique has also boosted the development of oligonucleotide product growth for diagnostic and therapeutic uses. For example, a large volume of oligonucleotide couples through biological ligands has been studied, which are more and more used in the analysis of numerous inherited ailments. Besides, progresses in the process of microchip-based oligonucleotide synthesis procedure have led to a surge in the quantity and decrease in the price of synthesis of oligonucleotides. Furthermore, progressions in the technologies of correcting the enzymatic error have abridged the incidence of faults in manufactured products. Thus, these progressions bolster the oligonucleotide synthesis market growth.
Increasing emphasis on personalized medication has a positive impact on the progress of oligonucleotide procedures. This kind of medicine offers custom-made medical treatment as per the needs of the patients. This process offers tailored solutions to patients. The beginning of anti-sense RNA therapy has increased the demand in the biotechnology sector. The possible application of tailored medicine for the treatment of diseases is attainable with oligonucleotide synthesis procedures. With progressions in the process of oligonucleotide synthesis, patients can be diagnosed and treated more efficiently.
The oligonucleotide synthesis market is divided into diagnostic laboratories, academic research institutes, pharmaceutical and biotechnology companies, and several others. The “others” category comprises food and beverage corporations and forensic labs. Amongst end-users, academic research institutes are having the largest share in the current scenario.
In the last few decades, amazing progress has been done on phosphoramidite chemistry-based significant de novo oligonucleotide synthesis has been attained, allowing many novel and exhilarating applications. Amongst them, de novo genome synthesis and DNA data storing are outstanding. Though for making these two applications more useful in the real world, the length, cost, and output of the synthesis need to be improved significantly. This challenge is properly met by phosphoramidite chemistry. Harnessing the influence of enzymes, the newly developed enzymatic method provides a competitive roadmap to deal with this challenge.
The increasing incidence of cancer is responsible for the ever-increasing demand for an oligonucleotide synthesis procedure.
SOURCE: P&S Intelligence
%20Pipe%20Market_29Apr21%20(2).jpg)
0 Comments